Related Experiment Video
Updated: Aug 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Late complications following the deployment of drug eluting stents
Dennis W T Nilsen1, Tor Melberg, Alf-Inge Larsen
1University of Bergen, Stavanger, Norway. Dennis.Nilsen@med.uib.no
Insights
Late stent thrombosis and stent-related aneurysms are serious complications of drug-eluting stents (DES). Paclitaxel-coated stents (Taxus-R) were implicated in these rare but severe events.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomaterials Science
Background:
- Drug-eluting stents (DES) are widely used to prevent restenosis after percutaneous coronary intervention.
- Late complications, including late stent thrombosis (LST) and stent-related aneurysms, have emerged as significant concerns.
- The paclitaxel-coated stent (Taxus-R) is a commonly utilized DES.
Observation:
- This report details two cases of late stent thrombosis (LST).
- One case of a stent-related aneurysm is also presented.
- All affected patients had received the paclitaxel-coated stent (Taxus-R).
Findings:
- Late stent thrombosis (LST) is a rare but potentially fatal complication associated with DES.
- Stent-related aneurysms represent another serious late adverse event.
- The paclitaxel-coated stent (Taxus-R) was identified in all presented cases.
Implications:
- These findings highlight the importance of monitoring for late stent-related complications even after successful stent implantation.
- Further research into the long-term safety and mechanisms of DES, particularly the Taxus-R stent, is warranted.
- Clinical vigilance for LST and stent-related aneurysms is crucial for patient management and outcomes.
Abstract:
Recently, attention has been focused on late complications related to drug eluting stents (DES) [Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-6; McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting stents after discontinuation of platelet therapy. Lancet 364 (2004) 1519-21; Eisenberg MJ. Drug-eluting stents: some bare facts. Lancet 364 (2004) 1466-7, [1-3]. We present two cases with late stent thrombosis (LST) and one case with a stent-related aneurysm. All patients were treated with the paclitaxel coated stent (Taxus-R) which is the most commonly used DES in our department.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Aneurysm III: Interprofessional Care
Healing II: Complications
Cardiac Catheterization II: Right Heart Catheterization